Test Price
2,800 AED✅ Home Collection Available
ALX4 Gene (Frontonasal Dysplasia Type 2) Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ALX4 Gene NGS Test in the UAE screens for pathogenic variants linked to Frontonasal Dysplasia Type 2 (FND2) using next‑generation sequencing with a guaranteed 3–4 week turnaround – priced at 2800 AED. This molecular diagnostic tool is essential for confirming clinical dysmorphology findings and guiding craniofacial surgical planning.
| Feature | Our Test (Home Collection) | Closest Alternative (Hospital Lab) |
|---|---|---|
| Precision | Full ALX4 gene NGS (99.9% sensitivity) | Targeted Sanger only (may miss novel variants) |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing (limited scope) |
| Turnaround | 3–4 Weeks | 4–6 Weeks |
| Home Collection | Yes – Cold‑Chain Certified | No |
Physician Insight & Safety Protocols
“Genetic testing for ALX4 is pivotal in confirming the diagnosis of Frontonasal Dysplasia Type 2, enabling families to access early intervention and tailored craniofacial care. A precise molecular diagnosis is the cornerstone of informed clinical management.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic testing does not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Do not proceed if the patient has an active febrile illness or uncontrolled bleeding disorder.
- Infants under 1 month require NICU clearance before blood draw.
- If the child develops acute respiratory distress, cyanosis, or seizure, seek immediate emergency care – test procedure cannot be performed until stable.
- All home collections follow DHA child protection protocols for pediatric care.
Patient FAQ & Clinical Guidance
1. What does the ALX4 gene test detect and why is it needed for my child?
Snippet: It identifies pathogenic variants in the ALX4 gene causing Frontonasal Dysplasia Type 2, which helps confirm a clinical dysmorphology diagnosis and guides surgical planning. The test is recommended when a child presents with hypertelorism, bifid nose, or midline facial clefts.
2. How is the sample collected and is it painful for my baby?
Snippet: We use a one-drop blood on FTA card or a small venipuncture (whole blood) collected by a paediatric phlebotomist using a butterfly needle, minimizing discomfort. The entire process takes less than three minutes and can be performed at home with cold-chain transport.
3. Will insurance cover this 2800 AED genetic test and how long for results?
Snippet: Many UAE insurers cover medically indicated genetic testing for dysmorphology when referred by a pediatrician or clinical geneticist; we verify eligibility via WhatsApp before the draw. Results are available within 3–4 weeks through our secure online portal with a telephonic clinical guidance session.
UAE Regulatory & Data Privacy Adherence
Our laboratory operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored securely, and accessible only to authorized clinical personnel. Test results are transmitted via a secure online portal, ensuring confidentiality and integrity throughout the diagnostic journey.
Clinical & Logistical Metadata
| Test Name | ALX4 Gene (Frontonasal Dysplasia Type 2) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) or FTA Card Dried Blood Spot |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Q75.8 |
| LOINC Code | 87611-7 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians